Biogen (Brazil) Analysis
| BIIB34 Stock | BRL 150.16 2.24 1.47% |
Biogen Inc is overvalued with Real Value of 121.63 and Hype Value of 150.16. The main objective of Biogen stock analysis is to determine its intrinsic value, which is an estimate of what Biogen Inc is worth, separate from its market price. There are two main types of Biogen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biogen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biogen's stock to identify patterns and trends that may indicate its future price movements.
The Biogen stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biogen's ongoing operational relationships across important fundamental and technical indicators.
Biogen |
Biogen Stock Analysis Notes
The book value of the company was currently reported as 14.82. The company recorded earning per share (EPS) of 16.9. Biogen Inc had not issued any dividends in recent years. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 7800 people. For more info on Biogen Inc please contact Christopher Viehbacher at 617 679 2000 or go to https://www.biogen.com.Biogen Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biogen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biogen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Biogen Inc generated a negative expected return over the last 90 days |
Biogen Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 218.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biogen's market, we take the total number of its shares issued and multiply it by Biogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biogen Profitablity
Biogen's profitability indicators refer to fundamental financial ratios that showcase Biogen's ability to generate income relative to its revenue or operating costs. If, let's say, Biogen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biogen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biogen's profitability requires more research than a typical breakdown of Biogen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.28 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29. Technical Drivers
As of the 23rd of December, Biogen shows the Mean Deviation of 0.9886, standard deviation of 1.6, and Risk Adjusted Performance of (0.14). Biogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biogen Inc Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biogen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biogen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biogen Predictive Daily Indicators
Biogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 150.16 | |||
| Day Typical Price | 150.16 | |||
| Price Action Indicator | (1.12) | |||
| Period Momentum Indicator | (2.24) |
Biogen Forecast Models
Biogen's time-series forecasting models are one of many Biogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biogen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biogen. By using and applying Biogen Stock analysis, traders can create a robust methodology for identifying Biogen entry and exit points for their positions.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 7800 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biogen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |